Contribution of extracellular signal-regulated kinases to the IL-1-induced growth inhibition of human melanoma cells A375

International Immunopharmacology

Volumn 8, Issue 1, 2008, Pages 80-89

  Arakawa, Tomohiro ^a   Yamamura, Takanori ^a   Hattori, Takayuki ^a,b   Hayashi, Hidetoshi ^a   Mori, Akiko ^a   Yoshida, Ayako ^a   Uchida, Chiharu ^b   Kitagawa, Masatoshi ^b   Onozaki, Kikuo ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CDK; Cytokines; E2F; ERK1 2; IL 1; Melanoma; p21; RB

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN A 375; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVONOIDS; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-1; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE INHIBITORS;

EID: 36649010976     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.10.013     Document Type: Article

References (46)

1. Cano E., and Mahadevan L.C. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20 (1995) 117-122
2. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267 (1995) 682-685
3. Han J., Lee J.D., Jiang Y., Li Z., Feng L., and Ulevitch R.J. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 271 (1996) 2886-2891
4. Matsuda S., Moriguchi T., Koyasu S., and Nishida E. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J Biol Chem 273 (1998) 12378-12382
5. Zhou G., Bao Z.Q., and Dixon J.E. Components of a new human protein kinase signal transduction pathway. J Biol Chem 270 (1995) 12665-12669
6. Dong C., Davis R.J., and Flavell R.A. Map kinases in the immune response. Annu Rev Immunol 20 (2002) 55-72
7. Nishida E., and Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18 (1993) 128-131
8. Cobb M.J., and Goldsmith E.J. How MAP kinases are regulated. J Biol Chem 270 (1995) 14843-14846
9. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8 (1996) 205-215
10. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., et al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270 (1995) 7420-7426
11. Galcheva-Gargova Z., Derijard B., Wu I.H., and Davis R.J. An osmosensing signal transduction pathway in mammalian cells. Science 265 (1994) 806-808
12. Kyriakis J.M., Banerjee M.P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., et al. The stress-activated protein kinase subfamily of c-jun kinases. Nature 369 (1994) 156-160
13. Wang X.Z., and Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP(GADD153) by p38MAP Kinase. Science 272 (1996) 1347-1349
14. Dinarello C.A. Biological basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
15. Gery I., Gershon R.K., and Waksman B.H. Potentiation of the T-lymphocytes response to mitogens. I. The responding cell. J Exp Med 136 (1972) 128-142
16. Freedman A.S., Freeman G., Whitman J., Segil J., Daley J., and Nadler J.M. Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation. J Immunol 141 (1988) 3398-3404
17. Schmidt J.A., Mizel S.B., Cohen D., and Green I. Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol 128 (1982) 2177-2182
18. Reimers J.I., Andersen H.U., Mauricio D., Pociot F., Karlsen A.E., Petersen J.S., et al. Strain-dependent differences in sensitivity of rat beta-cells to interleukin 1 beta in vitro and in vivo: association with islet nitric oxide synthesis. Diabetes 45 (1996) 771-778
19. Maier J.A., Voulalas P., Roeder D., and Maciag T. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science 249 (1990) 1570-1574
20. Onozaki K., Tamatani T., Hashimoto T., and Matsushima K. Growth inhibition and augmentation of mouse myeloid leukemic cell line differentiation by interleukin 1. Cancer Res 47 (1987) 2397-2402
21. Onozaki K., Matsushima K., Aggarwal B.B., and Oppenheim J.J. Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol 135 (1985) 3962-3968
22. Morinaga Y., Suzuki H., Takatsuki F., Akiyama Y., Taniyama T., Matsushima K., et al. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines. J Immunol 143 (1989) 3538-3542
23. Endo Y., Matsushima K., Onozaki K., and Oppenheim J.J. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor. J Immunol 141 (1988) 2342-2348
24. Yang D., Hayashi H., Takii T., Mizutani Y., Inukai Y., and Onozaki K. Interleukin-1-induced growth inhibition of human melanoma cells. Interleukin-1-induced antizyme expression is responsible for ornithine decarboxylase activity down-regulation. J Biol Chem 272 (1997) 3376-3383
25. Morinaga Y., Hayashi H., Takeuchi A., and Onozaki K. Antiproliferative effect of interleukin 1 (IL-1) on tumor cells: G0-G1 arrest of a human melanoma cell line by IL-1. Biochem Biophys Res Commun 173 (1990) 186-192
26. Itoh S., Hattori T., Hayashi H., Mizutani Y., Todo M., Takii T., et al. Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375. J Immunol 162 (1999) 7434-7440
27. Morooka T., and Nishida E. Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J Biol Chem 273 (1998) 24285-24288
28. Adachi T., Choudhury B.K., Stafford S., Sur S., and Alam R. The differetial role of extracellular-regulated kinases and p38 mitogen-activated protein kinase in eosinophil function. J Immunol 165 (2000) 2198-2204
29. Subbaramaiah K., Hart J.C., Norton L., and Dannenberg A.J. Microtuble-interfering agents atimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 and p38 mitogen-activated protein kinase pathways. J Biol Chem 275 (2000) 14838-14845
30. Harris V.K., Coticchia C.M., Kagan B.L., Ahmad S., Wellstein A., and Riegel A.T. Induction of the antiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 transduction pathways. J Biol Chem 275 (2000) 10802-10811
31. Gallagher T.F., Seibel G.L., Kassis S., Laydon J.T., Blumenthal M.J., Lee J.C., et al. Regulation of stress-induced cytokine production by pyridinylimidazoles inhibition of CSBP kinase. Bioorg Med Chem 5 (1997) 49-64
32. Miwa S., Uchida C., Kitagawa K., Hattori T., Oda T., Sugimura H., et al. Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner. Biochem Biophys Res Commun 340 (2006) 54-61
33. Kawamura S., Moriguchi T., and Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. J Biol Chem 274 (1999) 26563-26571
34. Berra E., Diaz-Meco M.T., and Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 273 (1998) 10792-10797
35. Yen A., Roberson M.S., Varvayanis S., and Lee A.T. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 58 (1998) 3263-3272
36. Wilkinson M., and Millar J. Control of the eukaryotic cell cycle by MAPK kinase signaling pathways. FASEB J 14 (2000) 2147-2157
37. Page K., Li J., and Hershenson M.B. Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin D1 promoter activity in cultured airway smooth-muscle cells. Role Ras. Am J Respir 20 (1999) 1294-1302
38. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., and Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogen signaling. Genes Dev 12 (1998) 3008-3019
39. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
40. Sewing A., Wiseman B., Lloyd A.C., and Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21 Clip. Mol Cell Biol 17 (1997) 5588-5597
41. Woods D., Parry D., Cherwinski H., Bosch E., Lees E., and McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Clip1. Mol Cell Biol 17 (1997) 5598-5611
42. 1-phase growth-arresting action of Interleukin-1 is independent of p53 and p21/WAF1 function. J Biol Chem 273 (1998) 30517-30523
43. Murai T., Nakagawa Y., Maeda H., and Terada K. Altered regulation of cell cycle machinery involved in interleukin-1-induced G(1) and G(2) phase growth arrest of A375S2 human melanoma cells. J Biol Chem 276 (2001) 6797-6806
44. 1 cell cycle arrest. Oncogene 23 (2004) 3284-3295
45. Muthukkumar S., Sells S.F., Crist S.A., and Rangnekar V.M. Interleukin-1 induces growth arrest by hypophosphorylation of the retinoblastoma susceptibility gene product RB. J Biol Chem 271 (1996) 5733-5740
46. Wang S., Nath N., Minden A., and Chellappan S. Regulation of RB and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J 18 (1999) 1559-1570